The Australian therapeutic Goods GOODS ADINISTRATRATRATRATIONA – which is used to lose weight – to treat sleep apnea, is a condition in which breathing stops and begins frequently during sleep.
The therapeutic commodity administration, according to the British Independent newspaper, pointed to the possibility of using “Mongro” to treat the medium NES to the extreme to obesity adults and have a 30 or higher body mass index (this indicator is calculated by dividing a person’s weight in kilograms by a square in meter).
The US Food and Drug Administration agreed to the same medicine to treat sleep apnea last year.
Obesity increases the risk of infection with sleep apnea by accumulating fat around the neck, which narrows the airway and affects breathing during sleep. How can this medicine, which is commonly used to control weight and cases such as type 2 diabetes, help people who suffer from sleep apnea?
What is sleeping breath?
Neom’s obstructive apnea affects nearly a billion people around the world. It is characterized by a frequent closure of the airway during sleep (called apnea), these blockages can be partial or complete, which means that breathing may become superficial or completely stop.
Repeated obstruction causes the patient to have intermittent sleep, and the airway blockage is disrupted by the flow of oxygen to the body, which strains the heart and contributes to increasing the risk of heart, blood vessels and metabolism, such as diabetes, high blood pressure and stroke.
Obesity is one of the main risk factors for obstructive sleep apnea, with about 80% of people with obesity. In fact, obesity and sleeplessness are associated with a bilateral direction, as obesity increases the risk of sleep in sleep, and vice versa.
Sleepy breath can contribute to weight gain by hormonal imbalances that regulate hunger (ghrelin) and satiety (leptin) signs, which makes it difficult to maintain a healthy weight and facilitate weight gain over time, leading to a vicious circle as each other exacerbates.
Loss of weight is an essential part of sleep -cutting treatment. It helps reduce the severity of the symptoms, and also reduces the risk of heart disease and other health problems that may arise as a result of it. However, achieving weight loss and maintaining it through lifestyle changes is difficult.
The Continuous Airway Pressure is the first to severe to extremely to severe sleep management. It connects a steady current of compressed air through a mask to keep the airway open during sleep, proving breathing and improving the quality of sleep.
Despite its effectiveness, many find the continuous positive airway pressure device that is uncomfortable, unattractive or difficult to use regularly, which may mean that people do not always adhere to it.
How can Monjaro help people with sleep apnea?
Terzopatide (the active substance in Monjao) works by simulating two hormonal futures in the intestine, namely the Bosinuous Airway Pressure and the Glucose-Dependent Insulinotropic dependent onsulinotropic Polypeptide).
These two hormones play a major role in organizing our appetite, the amount of food we eat, and blood sugar levels. Bulkid-like peptide-1 and insulinotropy-dependent in the body secrete in the body when eating, but by simulating their effects allows the Terzopatid people to feel full with smaller meals.
In a study conducted on 469 people who suffer from obesity and intermediate obstructive apnea to severe, one year of treatment was associated with Terzopatid with a decrease in the intensity of sleep -out of sleep by up to 60%, compared to a 3% decrease in people who received a fake treatment.
In addition, the evidence shows Terzopatid’s association with improvements in many major health indicators, such as reducing perfect inflammation, enhancing insulin sensitivity, and low blood pressure. These changes may improve respiratory functions, and help protect against heart, blood vessels and metabolism, which are common results of unconscious sleep apnea.
Are there any side effects?
While Monjoo may be useful for people with sleep apnea, intestinal side effects are relatively common with this medicine.
These effects can include nausea, vomiting, diarrhea, constipation, and loss of appetite. These side effects usually disappear as a person gets used to the medicine, and some patients also report gallbladder problems.
Despite these concerns, there is an interest in the Monjaro medicine as a treatment for sleeping breath, as it provides the first drug option for a case that traditionally relied on mechanical treatments such as continuous positive airway compression devices.
It is important to note that Montaru is recommended for use in obesity patients, and not all patients with sleep apnea suffer from weight gain or obesity.
Some patients suffer from a narrow structural structure, or problems in the upper airway, such as the large size of the soft palate that may reduce the air of the airway and make it more vulnerable to obstruction during sleep. In sleepless obesity, for these patients, non -drug therapeutic options may be needed, such as the lower jaw applications (oral devices that move the lower jaw forward and keep the airway open) and the surgery of the upper airway, to manage the condition effectively.